Money · Lobbying reports · 119th Congress
H.R. 1518
8 saved lobbying reports name H.R. 1518.
8 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 7, 2026 at 6:24 PM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Report |
|---|---|---|---|---|
| NATIONAL KIDNEY FOUNDATION | NATIONAL KIDNEY FOUNDATION | $80,000.00reported as expenses | April to June 2026 | Open the report |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | OTSUKA AMERICA PHARMACEUTICAL, INC. | $1,240,000.00reported as expenses | April to June 2026 | Open the report |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INCORPORATED | $1,200,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN SOCIETY OF NEPHROLOGY | AMERICAN SOCIETY OF NEPHROLOGY | $60,000.00reported as expenses | April to June 2026 | Open the report |
| TIBER CREEK GROUP | VERTEX PHARMACEUTICALS | $60,000.00reported as income | April to June 2026 | Open the report |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $140,000.00reported as expenses | April to June 2026 | Open the report |
| AMERICAN KIDNEY FUND | AMERICAN KIDNEY FUND | $240,000.00reported as expenses | April to June 2026 | Open the report |
| ALSTON & BIRD LLP | TRAVERE THERAPEUTICS | $70,000.00reported as income | April to June 2026 | Open the report |